awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q40261354-47B5B386-C23C-4E9B-BCB4-D7A87F8760D1
Q40261354-47B5B386-C23C-4E9B-BCB4-D7A87F8760D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40261354-47B5B386-C23C-4E9B-BCB4-D7A87F8760D1
An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes.
P2860
Q40261354-47B5B386-C23C-4E9B-BCB4-D7A87F8760D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40261354-47B5B386-C23C-4E9B-BCB4-D7A87F8760D1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8ab314ba4f3e9184904bdbee9b55e585dd22a18c
P2860
NF-κB inhibition by bortezomib permits IFN-γ-activated RIP1 kinase-dependent necrosis in renal cell carcinoma.